CorMedix (CRMD) Receivables - Other (2010 - 2024)

CorMedix (CRMD) reported Receivables - Other of $500000.0 for Q2 2024, up 1.24% sequentially from $493855.0 in Q4 2011.

CorMedix (CRMD) Receivables - Other (2010 - 2024) Analysis & Trends

CorMedix (CRMD) has 3 years of Receivables - Other data on file, last reported at $500000.0 in Q2 2024.

For the quarter ending Q2 2024, Receivables - Other changed N/A year-over-year to $500000.0; the trailing twelve-month figure through Jun 2024 stood at $500000.0 (changed N/A YoY), and the FY2011 full-year result was $493855.0, up 75.8% from the prior year.
Receivables - Other climbed to $500000.0 in Q2 2024, from $493855.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $500000.0 in Q2 2024 to a low of $500000.0 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	CorMedix	546.82 Mn	391.62 Mn	107.31 Mn

Download Data